The role of second-look laparotomy in the long-term survival in ovarian cancer
Authors:
- G. StraussGSG. Strauss
- B. LundBLB. Lund
Open Access
- 1 July 1997
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 8 (7) , 643-648
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Combined high-dose platinum and etoposide in previously untreated ovarian cancer patients with residual diseaseInternational Journal of Gynecological Cancer, 1996
- Long term survival by cytoreductive surgery to less than 1 cm, induction weekly cisplatin and monthly cisplatin, doxorubicin, and cyclophosphaide therapy in advanced ovarian adenocarcinomaCancer, 1994
- Long-Term Survival in Advanced Ovarian Cancer after Cytoreduction and Chemotherapy TreatmentGynecologic Oncology, 1994
- Long-term survival in ovarian cancerEuropean Journal of Cancer and Clinical Oncology, 1991
- Combined high-dose carboplatin and cisplatin, and ifosfamide in previously untreated ovarian cancer patients with residual disease.Journal of Clinical Oncology, 1990
- A randomized study of sequential versus alternating combination chemotherapy in advanced ovarian carcinomaAnnals of Oncology, 1990
- Survival after second-look laparotomy in advanced ovarian epithelial cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Another look at the second- assessment procedure for ovarian epithelial carcinomaAmerican Journal of Obstetrics and Gynecology, 1987
- A randomized study of single agent vs combination chemotherapy in FIGO stages IIB, III and IV ovarian adenocarcinomaEuropean Journal of Cancer and Clinical Oncology, 1985
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958